Knoxville, TN -- PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, Inc. is a registered supplier of investigational Deoxy-3[18F] Fluorothymidine (F-18 FLT) to the Society of Nuclear Medicine's Clinical Trial network. This was made possible via a cross reference from Siemens Molecular Imaging/PETNET's Drug Master File (DMF) to the SNM's centralized IND.

This is in addition to the National Cancer Institute's previous filing of a cross-reference letter to the same Type II Drug Master File that Siemens submitted to the U.S. Food and Drug Administration for its investigational 3 Deoxy-3[18F] Fluorothymidine (F-18 FLT). The cross reference allows F-18 FLT to be produced and used by any principle investigator in an NCI or SNM multi-center clinical trial.

The imaging biomarker will also be available to investigators outside of the NCI and SNM trials, if they receive independent FDA approval of an IND or appropriate approval, such as a local Radioactive Drug Research Committee (RDRC) approval. F-18 FLT has been used in studies monitoring the proliferative activity of cancer cells and it is currently being used in clinical trials at several research sites. This cross reference to Siemens Molecular Imaging/PETNET's DMF provides the medical community wider access to FLT by leveraging Siemens biomarker technology and the industry's largest network of PET biomarker production facilities.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries.

More HCB News